Cannell & Co’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-63,499
| Closed | -$347K | – | 255 |
|
|
2019
Q1 | $347K | Hold |
63,499
| – | – | 0.01% | 205 |
|
|
2018
Q4 | $193K | Sell |
63,499
-32,292
| -34% | -$98.1K | 0.01% | 232 |
|
|
2018
Q3 | $402K | Hold |
95,791
| – | – | 0.01% | 212 |
|
|
2018
Q2 | $370K | Hold |
95,791
| – | – | 0.01% | 214 |
|
|
2018
Q1 | $607K | Sell |
95,791
-128
| -0.1% | -$811 | 0.02% | 192 |
|
|
2017
Q4 | $774K | Sell |
95,919
-14,105
| -13% | -$114K | 0.03% | 186 |
|
|
2017
Q3 | $1.26M | Sell |
110,024
-26,838
| -20% | -$307K | 0.04% | 160 |
|
|
2017
Q2 | $1.34M | Sell |
136,862
-17,244
| -11% | -$168K | 0.05% | 154 |
|
|
2017
Q1 | $3.73M | Sell |
154,106
-45,820
| -23% | -$1.11M | 0.13% | 120 |
|
|
2016
Q4 | $6.42M | Sell |
199,926
-4,918
| -2% | -$158K | 0.23% | 95 |
|
|
2016
Q3 | $10.2M | Sell |
204,844
-382
| -0.2% | -$19.1K | 0.37% | 73 |
|
|
2016
Q2 | $8.7M | Buy |
205,226
+55,632
| +37% | +$2.36M | 0.32% | 78 |
|
|
2016
Q1 | $9.85M | Buy |
149,594
+15,989
| +12% | +$1.05M | 0.35% | 70 |
|
|
2015
Q4 | $7.75M | Hold |
133,605
| – | – | 0.25% | 83 |
|
|
2015
Q3 | $8.95M | Hold |
133,605
| – | – | 0.29% | 82 |
|
|
2015
Q2 | $13M | Buy |
133,605
+90,810
| +212% | +$8.83M | 0.37% | 72 |
|
|
2015
Q1 | $4M | Buy |
42,795
+1,271
| +3% | +$119K | 0.12% | 120 |
|
|
2014
Q4 | $3.69M | Buy |
41,524
+33,212
| +400% | +$2.95M | 0.11% | 117 |
|
|
2014
Q3 | $574K | Buy |
8,312
+1,271
| +18% | +$87.8K | 0.02% | 200 |
|
|
2014
Q2 | $404K | Buy |
7,041
+3,558
| +102% | +$204K | 0.01% | 212 |
|
|
2014
Q1 | $138K | Hold |
3,483
| – | – | ﹤0.01% | 267 |
|
|
2013
Q4 | $146K | Buy |
+3,483
| New | +$146K | 0.01% | 118 |
|